Search Results - "Derakhshani, Afshin"

Refine Results
  1. 1

    Current Approaches for Combination Therapy of Cancer: The Role of Immunogenic Cell Death by Asadzadeh, Zahra, Safarzadeh, Elham, Safaei, Sahar, Baradaran, Ali, Mohammadi, Ali, Hajiasgharzadeh, Khalil, Derakhshani, Afshin, Argentiero, Antonella, Silvestris, Nicola, Baradaran, Behzad

    Published in Cancers (23-04-2020)
    “…Cell death resistance is a key feature of tumor cells. One of the main anticancer therapies is increasing the susceptibility of cells to death. Cancer cells…”
    Get full text
    Journal Article
  2. 2

    Combination of Ipilimumab and Nivolumab in Cancers: From Clinical Practice to Ongoing Clinical Trials by Kooshkaki, Omid, Derakhshani, Afshin, Hosseinkhani, Negar, Torabi, Mitra, Safaei, Sahar, Brunetti, Oronzo, Racanelli, Vito, Silvestris, Nicola, Baradaran, Behzad

    “…Cytotoxic T-lymphocyte-associated protein 4 (CTLA-4) and programmed cell death protein 1 (PD-1) are inhibitory checkpoints that are commonly seen on activated…”
    Get full text
    Journal Article
  3. 3

    Overcoming trastuzumab resistance in HER2‐positive breast cancer using combination therapy by Derakhshani, Afshin, Rezaei, Zohreh, Safarpour, Hossein, Sabri, Morteza, Mir, Atefeh, Sanati, Mohammad Amin, Vahidian, Fatemeh, Gholamiyan Moghadam, Ali, Aghadoukht, Ali, Hajiasgharzadeh, Khalil, Baradaran, Behzad

    Published in Journal of cellular physiology (01-04-2020)
    “…Human epidermal growth factor receptor 2 (HER2)‐positive breast cancer (BC) comprises around 20–30% of all BC subtypes and is correlated with poor prognosis…”
    Get full text
    Journal Article
  4. 4

    Neutrophils, Crucial, or Harmful Immune Cells Involved in Coronavirus Infection: A Bioinformatics Study by Hemmat, Nima, Derakhshani, Afshin, Bannazadeh Baghi, Hossein, Silvestris, Nicola, Baradaran, Behzad, De Summa, Simona

    Published in Frontiers in genetics (09-06-2020)
    “…The latest member of the Coronaviridae family, called SARS-CoV-2, causes the Coronavirus Disease 2019 (COVID-19). The disease has caused a pandemic and is…”
    Get full text
    Journal Article
  5. 5

    The roles of signaling pathways in SARS-CoV-2 infection; lessons learned from SARS-CoV and MERS-CoV by Hemmat, Nima, Asadzadeh, Zahra, Ahangar, Noora Karim, Alemohammad, Hajar, Najafzadeh, Basira, Derakhshani, Afshin, Baghbanzadeh, Amir, Baghi, Hossein Bannazadeh, Javadrashid, Darya, Najafi, Souzan, Ar Gouilh, Meriadeg, Baradaran, Behzad

    Published in Archives of virology (01-03-2021)
    “…The number of descriptions of emerging viruses has grown at an unprecedented rate since the beginning of the 21 st century. Severe acute respiratory syndrome…”
    Get full text
    Journal Article
  6. 6

    Immune Checkpoints and CAR-T Cells: The Pioneers in Future Cancer Therapies? by Hosseinkhani, Negar, Derakhshani, Afshin, Kooshkaki, Omid, Abdoli Shadbad, Mahdi, Hajiasgharzadeh, Khalil, Baghbanzadeh, Amir, Safarpour, Hossein, Mokhtarzadeh, Ahad, Brunetti, Oronzo, Yue, Simon C, Silvestris, Nicola, Baradaran, Behzad

    “…Although the ever-increasing number of cancer patients pose substantial challenges worldwide, finding a treatment with the highest response rate and the lowest…”
    Get full text
    Journal Article
  7. 7

    MiR-144: A New Possible Therapeutic Target and Diagnostic/Prognostic Tool in Cancers by Kooshkaki, Omid, Rezaei, Zohre, Rahmati, Meysam, Vahedi, Parviz, Derakhshani, Afshin, Brunetti, Oronzo, Baghbanzadeh, Amir, Mansoori, Behzad, Silvestris, Nicola, Baradaran, Behzad

    “…MicroRNAs (miRNAs) are small and non-coding RNAs that display aberrant expression in the tissue and plasma of cancer patients when tested in comparison to…”
    Get full text
    Journal Article
  8. 8

    The Positive and Negative Immunoregulatory Role of B7 Family: Promising Novel Targets in Gastric Cancer Treatment by Bolandi, Nadia, Derakhshani, Afshin, Hemmat, Nima, Baghbanzadeh, Amir, Asadzadeh, Zahra, Afrashteh Nour, Mina, Brunetti, Oronzo, Bernardini, Renato, Silvestris, Nicola, Baradaran, Behzad

    “…Gastric cancer (GC), with a heterogeneous nature, is the third leading cause of death worldwide. Over the past few decades, stable reductions in the incidence…”
    Get full text
    Journal Article
  9. 9

    Immunomodulatory actions of vitamin D in various immune-related disorders: a comprehensive review by Ghaseminejad-Raeini, Amirhossein, Ghaderi, Ali, Sharafi, Amirmohammad, Nematollahi-Sani, Behrad, Moossavi, Maryam, Derakhshani, Afshin, Sarab, Gholamreza Anani

    Published in Frontiers in immunology (14-07-2023)
    “…For many years, vitamin D has been acknowledged for its role in maintaining calcium and phosphate balance. However, in recent years, research has assessed its…”
    Get full text
    Journal Article
  10. 10

    Deep learning applications in single-cell genomics and transcriptomics data analysis by Erfanian, Nafiseh, Heydari, A. Ali, Feriz, Adib Miraki, Iañez, Pablo, Derakhshani, Afshin, Ghasemigol, Mohammad, Farahpour, Mohsen, Razavi, Seyyed Mohammad, Nasseri, Saeed, Safarpour, Hossein, Sahebkar, Amirhossein

    Published in Biomedicine & pharmacotherapy (01-09-2023)
    “…Traditional bulk sequencing methods are limited to measuring the average signal in a group of cells, potentially masking heterogeneity, and rare populations…”
    Get full text
    Journal Article
  11. 11
  12. 12
  13. 13

    The Role of V-Domain Ig Suppressor of T Cell Activation (VISTA) in Cancer Therapy: Lessons Learned and the Road Ahead by Hosseinkhani, Negar, Derakhshani, Afshin, Shadbad, Mahdi Abdoli, Argentiero, Antonella, Racanelli, Vito, Kazemi, Tohid, Mokhtarzadeh, Ahad, Brunetti, Oronzo, Silvestris, Nicola, Baradaran, Behzad

    Published in Frontiers in immunology (19-05-2021)
    “…Immune checkpoints (ICs) have pivotal roles in regulating immune responses. The inhibitory ICs in the tumor microenvironment (TME) have been implicated in the…”
    Get full text
    Journal Article
  14. 14

    From Melanoma Development to RNA-Modified Dendritic Cell Vaccines: Highlighting the Lessons From the Past by Shadbad, Mahdi Abdoli, Hajiasgharzadeh, Khalil, Derakhshani, Afshin, Silvestris, Nicola, Baghbanzadeh, Amir, Racanelli, Vito, Baradaran, Behzad

    Published in Frontiers in immunology (22-02-2021)
    “…Although melanoma remains the deadliest skin cancer, the current treatment has not resulted in the desired outcomes. Unlike chemotherapy, immunotherapy has…”
    Get full text
    Journal Article
  15. 15

    Pancreatic Cancer Signaling Pathways, Genetic Alterations, and Tumor Microenvironment: The Barriers Affecting the Method of Treatment by Javadrashid, Darya, Baghbanzadeh, Amir, Derakhshani, Afshin, Leone, Patrizia, Silvestris, Nicola, Racanelli, Vito, Solimando, Antonio Giovanni, Baradaran, Behzad

    Published in Biomedicines (02-04-2021)
    “…Genetic alterations, especially the K-Ras mutation, carry the heaviest burden in the progression of pancreatic precursor lesions into pancreatic ductal…”
    Get full text
    Journal Article
  16. 16

    Silencing ZEB2 Induces Apoptosis and Reduces Viability in Glioblastoma Cell Lines by Safaee, Sahar, Fardi, Masoumeh, Hemmat, Nima, Khosravi, Neda, Derakhshani, Afshin, Silvestris, Nicola, Baradaran, Behzad

    Published in Molecules (Basel, Switzerland) (09-02-2021)
    “…Glioma is an aggressive type of brain tumor that originated from neuroglia cells, accounts for about 80% of all malignant brain tumors. Glioma aggressiveness…”
    Get full text
    Journal Article
  17. 17
  18. 18
  19. 19
  20. 20

    The Latest Findings of PD-1/PD-L1 Inhibitor Application in Gynecologic Cancers by Kooshkaki, Omid, Derakhshani, Afshin, Safarpour, Hossein, Najafi, Souzan, Vahedi, Parviz, Brunetti, Oronzo, Torabi, Mitra, Lotfinejad, Parisa, Paradiso, Angelo Virgilio, Racanelli, Vito, Silvestris, Nicola, Baradaran, Behzad

    “…Gynecologic cancers account for approximately 11% of the newly diagnosed cancers in women in the United States and for 18% globally. The presence of…”
    Get full text
    Journal Article